Hong Kong Stock Exchange · Healthcare
Invest in Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H stock from India
Indian and foreign residents can buy Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H (2335) shares directly through Paasa.
By Paasa · Updated
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H at a glance
- Price
- HK$20.80+HK$0.14 (0.68%)
- Market cap
- HK$5.82B
- Day range
- HK$20.50 – HK$21.14
- P/E
- —
- Dividend yield
- None
- Volume
- 270.80K
How to invest in Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 2335 and buy
Find Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H by name or by its ticker, 2335, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H from India
What Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H does
Shaanxi Mycotech Pharmaceutical Technology Co., Ltd. operates as a platform-based biotechnology company dedicated to accelerating the global innovation and development of next-generation bi-multi-specific peptide drugs. Its products include MT1013, which is a dual-targeting receptor agonist polypeptide that simultaneously targets the CaSR and the OGP receptor. Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H stock from India?
Yes. Indian residents and NRIs can buy Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H (2335) shares directly through Paasa. Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H is listed on the Hong Kong Stock Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$20.80 a share, size the order by the lot, not by the share.
How are Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H dividends taxed for Indian investors?
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.